5) Kim NK, et al : A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer. Cancer 71 : 3813-3818, 1993.
7) Ajani JA, et al : Docetaxel (D), cisplatin (C), 5-fluorouracil (F) compare to cisplatin (C) and 5-fluorouracil (F) for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma (MGC) : Interim results of a randomized phase III trial (V325). Proc ASCO 22 : 999, 2003.
10) Boku N, et al : Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912). Proc ASCO 26 : 4513, 2007.
11) Narahara H, et al : Randomized phase III study of S-1 alone versus S-1+cisplatin in the treatment for advanced gastric cancer (The SPIRITS trial) SPIRITS : S-1 plus cisplatin vs S-1 in RCT in the treatment for stomach cancer. Proc ASCO 26 : 4514, 2007.
16) Hattori Y, et al : Immunohistochemical detection of K-sam protein in stomach cancer. Clin Cancer Res 2 : 1373-1381, 1996.